Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the role of adipose tissue metabolism in the development of metabolic diseases, including obesity and diabetes. Research on the molecular mechanisms and potential therapeutic targets will be highlighted.
This session will focus on the latest advancements in gene and cell therapies aimed at treating inherited metabolic disorders. Presentations will cover novel approaches and clinical outcomes in gene therapy applications.
This track will address the interconnections between cardiovascular disorders, diabetes, and metabolic syndrome. Discussions will include innovative management strategies and emerging research findings.
This session will delve into the endocrine factors influencing metabolic diseases, including diabetes and obesity. The impact of hormonal regulation on metabolism and potential treatment avenues will be examined.
This track will cover the latest diagnostic techniques and treatment options for lysosomal storage disorders. Emphasis will be placed on the role of tandem mass spectrometry and emerging therapies.
This session will explore the relationship between nutrition, dietary interventions, and metabolic health. Research on how diet influences metabolic responses and disease outcomes will be presented.
This track will investigate the links between inflammation, cancer development, and metabolic disorders. Presentations will focus on the underlying mechanisms and potential therapeutic strategies.
This session will examine the surgical approaches to treating obesity and related metabolic disorders. Discussions will include patient outcomes, complications, and advancements in surgical techniques.
This track will focus on the emerging field of microbiome research and its impact on cardiometabolic diseases. Studies exploring the interactions between gut microbiota and metabolic health will be highlighted.
This session will address the unique challenges associated with diagnosing and treating metabolic disorders in pediatric populations. Innovations in newborn screening and early intervention strategies will be discussed.
This track will highlight cutting-edge therapies and treatment modalities for various metabolic diseases. Presentations will cover both pharmacological and non-pharmacological approaches to management.